Unveil mysterious “super-enhancers” in multiple myeloma Contributor Blood Cancer Behind the paper Unveil mysterious “super-enhancers” in multiple myeloma +1 Wee Joo Chng and 1 other Feb 18, 2021
Contributor Blood Cancer Behind the paper Refinement of prognosis and the effect of azacitidine in intermediate-risk myelodysplastic syndromes Konstantinos Liapis & Ioannis Kotsianidis, on behalf of the Hellenic National Registry of Myelodysplastic and Hypoplastic Syndromes. Konstantinos Liapis Feb 14, 2021
Contributor Nature Comms Behind the paper The Acquisition of Molecular Drivers in Pediatric Therapy-Related Myeloid Neoplasms Jason Schwartz Feb 12, 2021
Mass spectrometry is a highly sensitive peripheral blood marker for measurable residual disease in multiple myeloma Contributor Blood Cancer Behind the paper Mass spectrometry is a highly sensitive peripheral blood marker for measurable residual disease in multiple myeloma +2 Ben Derman and 2 others Feb 11, 2021
Metastatic dormancy in breast cancer depends on CD39+ PD-1+ CD8+ T cells Contributor Nature Comms Behind the paper Metastatic dormancy in breast cancer depends on CD39+ PD-1+ CD8+ T cells Paulino Tallón de Lara Feb 09, 2021
Three to tango – galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy Contributor Nature Comms Three to tango – galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy Riyao Yang Feb 06, 2021
The unexpected journey for targeted therapy in T-ALL Contributor Nature Cancer Behind the paper The unexpected journey for targeted therapy in T-ALL August John Feb 04, 2021
The single-cell transcriptomic landscape of peripheral blood and tumour derived from patients with nasopharyngeal carcinoma Contributor Nature Comms Behind the paper The single-cell transcriptomic landscape of peripheral blood and tumour derived from patients with nasopharyngeal carcinoma Yang Liu Feb 04, 2021
Cyclodextrin-based host-guest drug delivery system paves a way for synergetic intervention of tumor progression and inflammatory microenvironment against colorectal cancer Contributor Nature Comms Behind the paper Cyclodextrin-based host-guest drug delivery system paves a way for synergetic intervention of tumor progression and inflammatory microenvironment against colorectal cancer +1 Guping Tang and 1 other Feb 04, 2021
Identifying genetic factors driving disease progression in chronic lymphocytic leukemia Contributor Nature Comms Behind the paper Identifying genetic factors driving disease progression in chronic lymphocytic leukemia James Allan Feb 03, 2021
Improvements in bone mineral density after 5 years of anastrozole use in women at high risk of developing breast cancer Contributor BJC Behind the paper Improvements in bone mineral density after 5 years of anastrozole use in women at high risk of developing breast cancer Ivana Sestak Feb 01, 2021
Behind the Paper: Onco-ontogeny recapitulates phylogeny – a consideration. Contributor Behind the Paper: Onco-ontogeny recapitulates phylogeny – a consideration. Christina Plowman Feb 01, 2021
Targeting Metastatic Ewing Sarcoma via YAP/TAZ Inhibition Contributor Oncogenesis Behind the paper Targeting Metastatic Ewing Sarcoma via YAP/TAZ Inhibition Lisa Bierbaumer Jan 29, 2021
Activation of P2RX7 boosts antitumor immune responses and sensitizes tumors to immunotherapy Contributor Nature Comms Behind the paper Activation of P2RX7 boosts antitumor immune responses and sensitizes tumors to immunotherapy Serena Janho dit Hreich Jan 29, 2021
Contributor BJC Behind the paper Subsequent cancer risk among retinoblastoma survivors Sara J. Schonfeld Jan 27, 2021
Contributor Oncogene Behind the paper Cancer Researchers and Cancer Patients Communicating about Basic Science +3 Ravi Dhawan and 3 others Jan 26, 2021
Genetic link between premenopausal hormones and breast cancer risk Contributor BJC Behind the paper Genetic link between premenopausal hormones and breast cancer risk Nichola Johnson Jan 26, 2021
Biomolecular Condensation Drives Oncogenic Gene Expression Contributor Nature Structural Mol Biol Behind the paper Biomolecular Condensation Drives Oncogenic Gene Expression +1 Florian Grebien and 1 other Jan 22, 2021
In vivo synthetic lethal screen identifies drug synergies with immune checkpoint inhibitors Contributor Behind the paper In vivo synthetic lethal screen identifies drug synergies with immune checkpoint inhibitors +1 Dan Theodorescu and 1 other Jan 19, 2021
Epigenetics as a new target for treatment of bone disease in multiple myeloma Contributor Nature Comms Behind the paper Epigenetics as a new target for treatment of bone disease in multiple myeloma +2 Esteban Ballestar and 2 others Jan 18, 2021
